ifosfamide has been researched along with Solitary Fibrous Tumors in 3 studies
Solitary Fibrous Tumors: Rare neoplasms of mesenchymal origin, usually benign, and most commonly involving the PLEURA (see SOLITARY FIBROUS TUMOR, PLEURAL). They also are found in extrapleural sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, ZK | 1 |
| Liu, J | 1 |
| Chen, C | 1 |
| Yang, KY | 1 |
| Deng, YT | 1 |
| Jiang, Y | 1 |
| Stacchiotti, S | 2 |
| Libertini, M | 1 |
| Negri, T | 2 |
| Palassini, E | 1 |
| Gronchi, A | 2 |
| Fatigoni, S | 1 |
| Poletti, P | 1 |
| Vincenzi, B | 2 |
| Dei Tos, AP | 2 |
| Mariani, L | 1 |
| Pilotti, S | 2 |
| Casali, PG | 2 |
| Saponara, M | 1 |
| Frapolli, R | 1 |
| Tortoreto, M | 1 |
| Cominetti, D | 1 |
| Provenzano, S | 1 |
| Dagrada, GP | 1 |
| Colombo, C | 1 |
| Badalamenti, G | 1 |
| Zuco, V | 1 |
| Renne, SL | 1 |
| Collini, P | 1 |
| Morosi, C | 1 |
| Bello, E | 1 |
| D'Incalci, M | 1 |
| Zaffaroni, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| ERibulin in Advanced Solitary Fibrous Tumor, an ItaliaN Sarcoma Group Phase II Study (ERASING)[NCT03840772] | Phase 2 | 16 participants (Anticipated) | Interventional | 2019-07-17 | Recruiting | ||
| Solitary Fibrous Tumor: Phase II Study on Trabectedin Versus Adriamycin Plus Dacarbazine in Advanced Patients[NCT03023124] | Phase 2 | 50 participants (Anticipated) | Interventional | 2018-03-04 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for ifosfamide and Solitary Fibrous Tumors
| Article | Year |
|---|---|
Locally advanced malignant solitary fibrous tumour successfully treated with conversion chemotherapy, operation and postoperative radiotherapy: a case report.
Topics: Adolescent; Disease-Free Survival; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Male; Ne | 2021 |
Response to chemotherapy of solitary fibrous tumour: a retrospective study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relations | 2013 |
Response to chemotherapy of solitary fibrous tumour: a retrospective study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relations | 2013 |
Response to chemotherapy of solitary fibrous tumour: a retrospective study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relations | 2013 |
Response to chemotherapy of solitary fibrous tumour: a retrospective study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relations | 2013 |
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cerebellar | 2017 |